Steven Batki
Director, Addiction Research Program · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
- Present
Addiction Research Program · University of California (San Francisco) School of Medicine
Research
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Addiction · 1998 · 295 citations
Nature Genetics · 1996 · 215 citations
Pharmacological approaches to methamphetamine dependence: a focused review
Review · British Journal of Clinical Pharmacology · 2010 · Last of 6 authors · 173 citations
10 papers
10 papers
9 papers
8 papers
- ME
8 papers · 4 as a resident
8 papers
8 papers
- RJ
8 papers
Grants
- 2018–2023
Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder
National Institute on Alcohol Abuse and Alcoholism · R44
PI · $910.5K · Theranova, Llc
- 2013–2019
Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM with High-r
National Institute on Drug Abuse · R01
PI · $1.8M · Public Health Foundation Enterprises
- 2011–2017
Naltrexone for the Treatment of Actively-Using Met-Dependent MSM with High-Risk B
National Institute on Drug Abuse · R01
PI · $2.3M · Public Health Foundation Enterprises
- 2003–2010
Improving Hepatitis C Treatment in Injection Drug Users
National Institute on Drug Abuse · R01
Contact PI · $3.5M · Northern California Institute/Res/Edu
Clinical trials
- 2021–2023
Opioid Approach Bias Modification
Principal investigator · Completed
University of California, San Francisco
- 2019–2020
Principal investigator · Completed
University of California, San Francisco
- 2018–2019
Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)
Principal investigator · Completed · Phase 2
University of California, San Francisco
- 2016–2018
N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
Principal investigator · Completed · Phase 2
University of California, San Francisco